Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Avanos Medical ( (AVNS) ) is now available.
On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its new Chief Executive Officer, effective April 14, 2025. Pacitti, who previously held leadership roles at Siemens Healthineers and Abbott Vascular, brings extensive industry expertise and a strategic vision to the company. His appointment is expected to drive Avanos’s next phase of growth and success, with a focus on delivering breakthrough medical device solutions and enhancing long-term value for stakeholders.
More about Avanos Medical
Avanos Medical (NYSE: AVNS) is a medical technology company headquartered in Alpharetta, Georgia. The company focuses on delivering clinically superior medical device solutions aimed at improving patient quality of life, including providing nutrition support from hospital to home and reducing opioid use during recovery. Avanos develops, manufactures, and markets its products globally, holding leading market positions in various product categories.
YTD Price Performance: -8.65%
Average Trading Volume: 523,744
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $665.2M
Learn more about AVNS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue